Rational Advisors’s Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A BSX.PRA Stock Holding History

Rational Advisors’s Portfolio BSX.PRA Stock Details BSX.PRA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-18,935	Closed	-$2.28M	–	307
2023 Q1	$2.28M	Sell	18,935 -23,200	-55%	-$2.67M	0.19%	50
2022 Q4	$4.84M	Hold	42,135	–	–	0.4%	28
2022 Q3	$4.31M	Hold	42,135	–	–	0.34%	26
2022 Q2	$4.28M	Buy	42,135 +5,500	+15%	+$600K	0.31%	27
2022 Q1	$4.26M	Buy	36,635 +15,700	+75%	+$1.82M	0.25%	34
2021 Q4	$2.38M	Buy	+20,935	New	+$2.39M	0.15%	54
2021 Q2	–	Sell	-35,135	Closed	-$3.8M	–	198
2021 Q1	$3.8M	Buy	35,135 +14,570	+71%	+$1.61M	0.7%	27
2020 Q4	$2.25M	Hold	20,565	–	–	0.6%	34
2020 Q3	$2.29M	Buy	20,565 +5,390	+36%	+$604K	0.98%	20
2020 Q2	$1.59M	Buy	+15,175	New	+$1.63M	0.82%	33

Other funds holding BSX.PRA

LTI

Laffer Tengler Investments Nashville, Tennessee $782M AUM 33.6% 1-Year Est. Return

Rational Advisors's BSX.PRA Position: Q2 2023 in Review

Rational Advisors sold out of Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A (BSX.PRA) in Q2 2023, closing a stake of 18,935 shares — an estimated $2.28M sold.

Rational Advisors first reported a position in BSX.PRA in Q2 2020 and held it in 10 quarters. The position peaked at $4.84M in Q4 2022. 1 fund tracked by Wall St. Rank holds BSX.PRA as of Q2 2023.

Rational Advisors reported no remaining Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A position as of Q2 2023 after selling out during the quarter.
Rational Advisors sold 18,935 Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A shares in Q2 2023, an estimated $2.28M.
Rational Advisors first reported a position in Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A in Q2 2020 and held it in 10 quarters.
Rational Advisors's Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A position peaked at $4.84M in Q4 2022.
1 fund tracked by Wall St. Rank held Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A as of Q2 2023.

Based on Rational Advisors's 13F filing for Q2 2023, filed 8 Aug 2023.